Showing 1–12 of 24 results

Exjade 250 mg Alternative – Deferox (Deferasirox) 250 mg Tablet | Beacon Pharmaceuticals

Deferox 250 mg (Deferasirox) Tablet by Beacon Pharmaceuticals. Reference brand: Exjade. oral iron chelator; used in chronic iron overload requiring chelation. Prescription medicine. Brand comparison does not establish interchangeability.

Exjade 500 mg Alternative – Deferox (Deferasirox) 500 mg Tablet | Beacon Pharmaceuticals

Deferox 500 mg (Deferasirox) Tablet by Beacon Pharmaceuticals. Reference brand: Exjade. oral iron chelator; used in chronic iron overload requiring chelation. Prescription medicine. Brand comparison does not establish interchangeability.

Gleevec / Glivec 100 mg Alternative – Imacent (Imatinib) 100 mg Tablet | Incepta Pharmaceuticals

Imacent 100 mg (Imatinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Gleevec / Glivec (Novartis).

Pack: 30 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Gleevec / Glivec 400 mg Alternative – Imacent (Imatinib) 400 mg Tablet | Incepta Pharmaceuticals

Imacent 400 mg (Imatinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Gleevec / Glivec (Novartis).

Pack: 30 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Gleevec 100 mg Alternative – Imanix (Imatinib) 100 mg Tablet | Beacon Pharmaceuticals

Imanix 100 mg (Imatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Gleevec. BCR-ABL/KIT inhibitor; used in selected chronic myeloid leukemia and gastrointestinal stromal tumors. Prescription medicine. Brand comparison does not establish interchangeability.

Gleevec 400 mg Alternative – Imanix (Imatinib) 400 mg Tablet | Beacon Pharmaceuticals

Imanix 400 mg (Imatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Gleevec. BCR-ABL/KIT inhibitor; used in selected chronic myeloid leukemia and gastrointestinal stromal tumors. Prescription medicine. Brand comparison does not establish interchangeability.

Humira 40 mg Alternative – Advixa (Adalimumab) 40 mg Injection | Incepta Pharmaceuticals

Advixa 40 mg (Adalimumab) Injection is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Humira (AbbVie).

Pack: 1 prefilled syringe. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Hydrea 500 mg Alternative – Hydronix (Hydroxyurea) 500 mg Capsule | Beacon Pharmaceuticals

Hydronix 500 mg (Hydroxyurea) Capsule by Beacon Pharmaceuticals. Reference brand: Hydrea. antimetabolite; used in selected blood disorders including sickle cell disease and myeloproliferative conditions. Prescription medicine. Brand comparison does not establish interchangeability.

Imbruvica 140 mg Alternative – Ibrucent (Ibrutinib) 140 mg Capsule | Incepta Pharmaceuticals

Ibrucent 140 mg (Ibrutinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Imbruvica (Pharmacyclics / Janssen).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Imbruvica 140 mg Alternative – Ibrucor (Ibrutinib) 140 mg Capsule | Beacon Pharmaceuticals

Ibrucor 140 mg (Ibrutinib) Capsule by Beacon Pharmaceuticals. Reference brand: Imbruvica. BTK inhibitor; used in selected B-cell malignancies. Prescription medicine. Brand comparison does not establish interchangeability.

Jakafi / Jakavi 10 mg Alternative – Rulicent (Ruxolitinib) 10 mg Tablet | Incepta Pharmaceuticals

Rulicent 10 mg (Ruxolitinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Jakafi / Jakavi (Incyte / Novartis).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Jakafi / Jakavi 5 mg Alternative – Rulicent (Ruxolitinib) 5 mg Tablet | Incepta Pharmaceuticals

Rulicent 5 mg (Ruxolitinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Jakafi / Jakavi (Incyte / Novartis).

Pack: 14 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.